Sandoz Group AG (SDZXF)

OTCMKTS · Delayed Price · Currency is USD
60.08
-0.22 (-0.37%)
At close: Sep 11, 2025
-0.37%
Market Cap25.35B
Revenue (ttm)10.59B
Net Income (ttm)227.00M
Shares Outn/a
EPS (ttm)0.52
PE Ratio111.66
Forward PE16.44
Dividend0.73 (1.22%)
Ex-Dividend DateApr 17, 2025
Volume125
Average Volume1,352
Open60.08
Previous Close60.30
Day's Range60.08 - 60.08
52-Week Range36.68 - 62.16
Betan/a
RSI68.45
Earnings DateOct 30, 2025

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland. [Read more]

Sector Healthcare
Founded 1886
Employees 22,049
Stock Exchange OTCMKTS
Ticker Symbol SDZXF
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.